September 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev further increased his interest in the company through 21 transactions on the regulated market of the Bulgarian Stock Exchange on September 16.
Donev bought 22,300 shares in Sopharma in deals priced at 3.10 levs ($1.87/1.58 euro) per share, the drug manufacturer said in a bourse filing.
You can subscribe to our M&A newsletter here
Donev has directly acquired a total of 121,300 shares in Sopharma, or 0.090% interest, so far this month.
Indirectly, Donev is the biggest shareholder in Sopharma, as he controls a 25.67% stake through Donev Investments Holding. Donev is also a major shareholder in Sopharma's second-biggest shareholder Telecomplect Invest, which controls 20.68% interest in Sopharma.
As at 16:00 CET on Thursday Sopharma's shares traded 0.65% higher at 3.12 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)